Tumor necrosis factor messenger RNA (TNF mRNA) (TNF mRNA)

Tumor necrosis factor alpha (TNF-alpha) messenger RNA (mRNA) is the primary transcript of the TNF gene (NCBI Gene ID: 7124) and serves as the essential template for the synthesis of the TNF-alpha protein, a master regulator of the mammalian inflammatory response (PubMed: 21172260). The stability and translational efficiency of this mRNA are tightly controlled by regulatory sequences in its 3' untranslated region, most notably AU-rich elements (AREs), which allow the cell to rapidly modulate cytokine production in response to immune stimuli (PubMed: 15123770). In chronic inflammatory and autoimmune conditions such as rheumatoid arthritis and Crohn's disease, dysregulation of TNF-alpha mRNA leads to the sustained overproduction of the cytokine, driving tissue destruction and systemic inflammation. Therapeutic strategies targeting the mRNA, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), aim to silence gene expression at the pre-translational stage. This approach, exemplified by investigational agents like ISIS 104838, offers a potential advantage over traditional protein-targeting biologics by reducing the total cellular burden of the cytokine and potentially overcoming resistance seen with monoclonal antibodies (PubMed: 12428229).

Other names

TNF-alpha mRNATNFA mRNACachectin mRNATumor necrosis factor alpha RNA

Antisense-mediated RNase H degradation of mRNA; RNA interference (RNAi) via the RNA-induced silencing complex (RISC)